Lipid metabolism analysis in esophageal cancer and associated drug discovery

Ruidi Jiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Chao Zhao(Hong Kong Baptist University), Lühua Wang(The University of Texas MD Anderson Cancer Center), Wei Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Kunpeng Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Qian Luo(Chinese Academy of Sciences)
Journal of Pharmaceutical Analysis
September 1, 2023
10.1016/j.jpha.2023.08.019
Cited by 20

Related Papers

The Bruton's Tyrosine Kinase Inhibitor PCI-32765 Is Highly Active As Single-Agent Therapy in Previously-Treated Mantle Cell Lymphoma (MCL): Preliminary Results of a Phase II Trial
|Blood|2011|41
<p>Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities</p>
|OncoTargets and Therapy|2019|39
Apatinib induces apoptosis and autophagy via the PI3K/AKT/mTOR and MAPK/ERK signaling pathways in neuroblastoma
|Oncology Letters|2020|33
Effects of PM2.5 exposure in utero on heart injury, histone acetylation and GATA4 expression in offspring mice
|Chemosphere|2020|31
IDO1 Expression Increased After Neoadjuvant Therapy Predicts Poor Pathologic Response and Prognosis in Esophageal Squamous Cell Carcinoma
|Frontiers in Oncology|2020|21